Pilgrim Software Partners with Virtify to Offer Electronic Regulatory Submissions Solution
September 18, 2008
TAMPA, FL – Pilgrim Software, Inc., a provider of Enterprise Compliance and Quality Management (ECQM) software solutions, announced a strategic partnership with Virtify Inc., a global producer of web-based software solutions for the Life Sciences industry, to jointly provide an Electronic Regulatory Submissions solution for complete lifecycle management of the regulatory submissions process. Together, Pilgrim and Virtify will support the submissions efforts of enterprises, from emerging growth companies with a single product, to global companies issuing submissions in dozens of countries with different format requirements. Pilgrim’s Regulatory Submissions solution enables electronic submissions to speed manufacturers’ product approvals and time to market.
The joint offering is based on industry-leading applications, built on Microsoft .NET and XML technology: Pilgrim’s SmartDoc™ document management solution integrated with Virtify’s Virtx eCTD platform.
The Regulatory Submissions solution provides all the elements needed for eCTD or non-eCTD electronic submissions (NEES), and will help organizations prepare for the global mandates by regulatory agencies.
Using this offering from Pilgrim and Virtify, companies will gain complete control over the submission document lifecycle, from streamlining submission planning, preparation and tracking, to high-quality and seamless assembly and publishing. The web-based automated product also ensures improved quality control and timely distribution.
"Virtify’s vision is to provide people with the software tools that will enable them to collaborate and work in an integrated environment that’s based on evolving standards," said Satish Tadikonda, President of Virtify Inc. "Pilgrim shares that vision, so in partnering with Pilgrim to provide the Regulatory Submissions solution, we’re enabling companies to take on the evolving regulatory landscape and strengthen their ability to meet both the challenges and the opportunities for success in the Life Sciences Industry."